CTNM: Contineum Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | BALYASNY ASSET MANAGEMENT L.P. | 7.14% | SEC | |
| 2026-07-27 | New 13G stake | BlackRock, Inc. | 6.30% | SEC |
Institutional ownership (Q2 2026)
102 institutions reported holding $500.01M of Contineum Therapeutics, Inc. on Form 13F (90 the quarter before). 28 opened a new position and 15 sold out. Shares held by institutions: same.
| Largest holders | Shares | Value |
|---|---|---|
| MONTANOVA CAPITAL, LLC | 2,841,334 | $46.57M |
| Jupiter Topco LLC | 2,734,836 | $44.77M |
| BlackRock, Inc. | 2,064,345 | $33.83M |
| JOHNSON & JOHNSON | 1,979,173 | $32.44M |
| FRANKLIN RESOURCES INC | 1,839,227 | $30.14M |
| Balyasny Asset Management L.P. | 1,522,793 | $24.96M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,321,356 | $21.66M |
| PERCEPTIVE ADVISORS LLC | 1,255,592 | $20.58M |
| FMR LLC | 1,040,130 | $17.05M |
| MILLENNIUM MANAGEMENT LLC | 931,709 | $15.27M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.